Given the heterogeneity of evidence across this field, greater interpretive weight was placed on human studies, well-characterized animal models, and recent high-quality reviews
Benefits for People With Type 2 Diabetes People with type 2 diabetes saw two noticeable improvements: Lower blood sugar levels , including meaningful HbA1c reductions Steady weight loss , though typically a little less than non-diabetic participants a pattern also seen with injected GLP-1 receptor agonists The blood sugar improvements reflect how GLP-1 receptor agonists support insulin activity and slow digestion, which may help stabilise glucose throughout the day
Clinical trials show that weekly injections lead to greater average reduction in body weight and semaglutide works fast, particularly in non-diabetic patients
& Puzianowska-Kuznicka, M
As described above, there is compelling evidence that significant tissue-level cobalamin deficiency is present in some companion animal patients with gastrointestinal disease
Hallmarks of ferroptosis
